240 related articles for article (PubMed ID: 20658466)
21. [Nonalcoholic fatty liver disease as a risk factor of cardiovascular disease: relation of non-alcoholic fatty liver disease to carotid atherosclerosis].
Choi SY; Kim D; Kang JH; Park MJ; Kim YS; Lim SH; Kim CH; Lee HS
Korean J Hepatol; 2008 Mar; 14(1):77-88. PubMed ID: 18367860
[TBL] [Abstract][Full Text] [Related]
22. Association of serum gamma-glutamyltransferase and alanine aminotransferase activities with risk of type 2 diabetes mellitus independent of fatty liver.
Kim CH; Park JY; Lee KU; Kim JH; Kim HK
Diabetes Metab Res Rev; 2009 Jan; 25(1):64-9. PubMed ID: 19065605
[TBL] [Abstract][Full Text] [Related]
23. Elevated alanine aminotransferase levels predict mortality from cardiovascular disease and diabetes in Koreans.
Yun KE; Shin CY; Yoon YS; Park HS
Atherosclerosis; 2009 Aug; 205(2):533-7. PubMed ID: 19159884
[TBL] [Abstract][Full Text] [Related]
24. γ-Glutamyltransferase, but not markers of hepatic fibrosis, is associated with cardiovascular disease in older people with type 2 diabetes mellitus: the Edinburgh Type 2 Diabetes Study.
Morling JR; Fallowfield JA; Williamson RM; Robertson CM; Glancy S; Guha IN; Strachan MW; Price JF
Diabetologia; 2015 Jul; 58(7):1484-93. PubMed ID: 25820150
[TBL] [Abstract][Full Text] [Related]
25. Liver enzymes and incident diabetes in China: a prospective analysis of 10 764 participants in the Guangzhou Biobank Cohort Study.
Xu L; Jiang CQ; Schooling CM; Zhang WS; Cheng KK; Lam TH
J Epidemiol Community Health; 2015 Nov; 69(11):1040-4. PubMed ID: 26139641
[TBL] [Abstract][Full Text] [Related]
26. Increased risk of type 2 diabetes in subjects with both elevated liver enzymes and ultrasonographically diagnosed nonalcoholic fatty liver disease: a 4-year longitudinal study.
Choi JH; Rhee EJ; Bae JC; Park SE; Park CY; Cho YK; Oh KW; Park SW; Lee WY
Arch Med Res; 2013 Feb; 44(2):115-20. PubMed ID: 23398788
[TBL] [Abstract][Full Text] [Related]
27. Risk factors associated with nonalcoholic fatty liver disease and its relationship with the hepatic histological changes.
Rodríguez-Hernández H; Gonzalez JL; Márquez-Ramirez MD; Flores-Hernandez M; Rodríguez-Morán M; Guerrero-Romero F
Eur J Gastroenterol Hepatol; 2008 May; 20(5):399-403. PubMed ID: 18403941
[TBL] [Abstract][Full Text] [Related]
28. Liver enzymes: potential cardiovascular risk markers?
Lioudaki E; Ganotakis ES; Mikhailidis DP
Curr Pharm Des; 2011 Nov; 17(33):3632-43. PubMed ID: 22074433
[TBL] [Abstract][Full Text] [Related]
29. Cardiovascular risk factors, nonalcoholic fatty liver disease, and carotid artery intima-media thickness in an adolescent population in southern Italy.
Caserta CA; Pendino GM; Amante A; Vacalebre C; Fiorillo MT; Surace P; Messineo A; Surace M; Alicante S; Cotichini R; Zuin M; Rosmini F; Mele A; Marcucci F
Am J Epidemiol; 2010 Jun; 171(11):1195-202. PubMed ID: 20457571
[TBL] [Abstract][Full Text] [Related]
30. Low alanine aminotransferase levels and higher number of cardiovascular events in people with Type 2 diabetes: analysis of the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study.
Williams KH; Sullivan DR; Veillard AS; O'Brien R; George J; Jenkins AJ; Young S; Ehnholm C; Duffield A; Twigg SM; Keech AC
Diabet Med; 2016 Mar; 33(3):356-64. PubMed ID: 26433207
[TBL] [Abstract][Full Text] [Related]
31. Higher concentrations of alanine aminotransferase within the reference interval predict nonalcoholic fatty liver disease.
Chang Y; Ryu S; Sung E; Jang Y
Clin Chem; 2007 Apr; 53(4):686-92. PubMed ID: 17272484
[TBL] [Abstract][Full Text] [Related]
32. Risk of severe liver disease in nonalcoholic fatty liver disease with normal aminotransferase levels: a role for insulin resistance and diabetes.
Fracanzani AL; Valenti L; Bugianesi E; Andreoletti M; Colli A; Vanni E; Bertelli C; Fatta E; Bignamini D; Marchesini G; Fargion S
Hepatology; 2008 Sep; 48(3):792-8. PubMed ID: 18752331
[TBL] [Abstract][Full Text] [Related]
33. Serum retinol-binding protein 4 in patients with nonalcoholic fatty liver disease: does it have a significant impact on pathogenesis?
Cengiz C; Ardicoglu Y; Bulut S; Boyacioglu S
Eur J Gastroenterol Hepatol; 2010 Jul; 22(7):813-9. PubMed ID: 19820404
[TBL] [Abstract][Full Text] [Related]
34. Elevated serum alanine aminotransferase and gamma-glutamyltransferase and mortality in the United States population.
Ruhl CE; Everhart JE
Gastroenterology; 2009 Feb; 136(2):477-85.e11. PubMed ID: 19100265
[TBL] [Abstract][Full Text] [Related]
35. Alanine aminotransferase, gamma-glutamyltransferase, and incident diabetes: the British Women's Heart and Health Study and meta-analysis.
Fraser A; Harris R; Sattar N; Ebrahim S; Davey Smith G; Lawlor DA
Diabetes Care; 2009 Apr; 32(4):741-50. PubMed ID: 19131466
[TBL] [Abstract][Full Text] [Related]
36. Ultrasonographic hepatic steatosis increases prediction of mortality risk from elevated serum gamma-glutamyl transpeptidase levels.
Haring R; Wallaschofski H; Nauck M; Dörr M; Baumeister SE; Völzke H
Hepatology; 2009 Nov; 50(5):1403-11. PubMed ID: 19670414
[TBL] [Abstract][Full Text] [Related]
37. Cholelithiasis and markers of nonalcoholic fatty liver disease in patients with metabolic risk factors.
Koller T; Kollerova J; Hlavaty T; Huorka M; Payer J
Scand J Gastroenterol; 2012 Feb; 47(2):197-203. PubMed ID: 22182015
[TBL] [Abstract][Full Text] [Related]
38. Fatty liver is associated with an increased risk of diabetes and cardiovascular disease - Evidence from three different disease models: NAFLD, HCV and HIV.
Lonardo A; Ballestri S; Guaraldi G; Nascimbeni F; Romagnoli D; Zona S; Targher G
World J Gastroenterol; 2016 Nov; 22(44):9674-9693. PubMed ID: 27956792
[TBL] [Abstract][Full Text] [Related]
39. Nonalcoholic fatty liver disease (NAFLD): a new risk factor for adverse cardiovascular events in dialysis patients.
Mikolasevic I; Racki S; Zaputovic L; Lukenda V; Milic S; Orlic L
Med Hypotheses; 2014 Feb; 82(2):205-8. PubMed ID: 24365277
[TBL] [Abstract][Full Text] [Related]
40. Elevation of serum aminotransferase activity increases risk of carotid atherosclerosis in patients with non-alcoholic fatty liver disease.
Wang CC; Lin SK; Tseng YF; Hsu CS; Tseng TC; Lin HH; Wang LY; Kao JH
J Gastroenterol Hepatol; 2009 Aug; 24(8):1411-6. PubMed ID: 19702910
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
